Citadel Advisors’s CARGO Therapeutics CRGX Stock Holding History

Citadel Advisors’s Portfolio CRGX Stock Details CRGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-507,418	Closed	-$2.09M	–	12929
2025 Q2	$2.09M	Buy	507,418 +438,312	+634%	+$1.88M	﹤0.01%	5625
2025 Q1	$281K	Buy	+69,106	New	+$463K	﹤0.01%	9743
2024 Q1	–	Sell	-196,889	Closed	-$4.56M	–	14662
2023 Q4	$4.56M	Buy	+196,889	New	+$3.34M	﹤0.01%	3929

Other funds holding CRGX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Citadel Advisors's CRGX Position: Q3 2025 in Review

Citadel Advisors sold out of CARGO Therapeutics (CRGX) in Q3 2025, closing a stake of 507,418 shares — an estimated $2.09M sold.

Citadel Advisors first reported a position in CRGX in Q4 2023 and held it in 3 quarters. The position peaked at $4.56M in Q4 2023. 1 fund tracked by Wall St. Rank holds CRGX as of Q3 2025.

Citadel Advisors reported no remaining CARGO Therapeutics position as of Q3 2025 after selling out during the quarter.
Citadel Advisors sold 507,418 CARGO Therapeutics shares in Q3 2025, an estimated $2.09M.
Citadel Advisors first reported a position in CARGO Therapeutics in Q4 2023 and held it in 3 quarters.
Citadel Advisors's CARGO Therapeutics position peaked at $4.56M in Q4 2023.
1 fund tracked by Wall St. Rank held CARGO Therapeutics as of Q3 2025.

Based on Citadel Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.